IceCure Medical announces regulatory approval of ProSense System in Canada

IceCure Medical, announced that Health Canada, the Canadian government’s regulatory agency, has approved IceCure’s ProSense System, disposable cryoprobes, and introducers as cryosurgical tools for indications including tumors – ablation of benign and malignant tumors of the lung, liver, kidneys, and musculoskeletal system, and benign tumors of the breast; General surgery; palliative intervention; and ther surgeries.